Table 2
Invasive Cancer Incidence by Primary Site and Age at Diagnosis
Michigan Residents, 2015

Primary Site
  (ICD-O-3 Cancer Incidence
Site Groupings)
 
Total Less than 50 Years 50 - 74 Years 75 Years & Over
Number Age-
Adjusted
Rate
Number Age-
Specific
Rate
Number Age-
Specific
Rate
Number Age-
Specific
Rate
Gastrointestinal Tract
& Digestive System
10,662 86.2 ±1.6 901 14.4 ±0.9 6,587 218.9 ±5.1 3,174 478.8 ±15.7
Lip, Oral Cavity & Pharynx 1,400 11.1 ±0.6 141 2.3 ±0.4 996 33.1 ±2.0 263 39.7 ±4.8
Stomach 716 5.9 ±0.4 67 1.1 ±0.3 403 13.4 ±1.3 246 37.1 ±4.6
Colon 3,104 25.7 ±0.9 289 4.6 ±0.5 1,664 55.3 ±2.6 1,151 173.6 ±9.8
Rectum 1,426 11.7 ±0.6 197 3.2 ±0.4 940 31.2 ±2.0 289 43.6 ±5.0
Pancreas 1,686 13.5 ±0.6 72 1.2 ±0.3 1,018 33.8 ±2.1 596 89.9 ±7.1
Other Gastrointestinal
Tract & Digestive System
2,330 18.3 ±0.7 135 2.2 ±0.4 1,566 52.0 ±2.6 629 94.9 ±7.3
Respiratory System &
Pleura
8,416 67.1 ±1.4 290 4.6 ±0.5 5,416 180.0 ±4.7 2,710 408.8 ±14.6
Larynx 494 3.8 ±0.3 28 0.4 ±0.2 380 12.6 ±1.3 86 13.0 ±2.7
Lung & Bronchus 7,839 62.6 ±1.4 245 3.9 ±0.5 4,990 165.8 ±4.5 2,604 392.8 ±14.4
Other Respiratory 83 0.7 ±0.2 17 0.3 ±0.1 46 1.5 ±0.4 20 3.0 ±1.3
Bones & Soft Tissue 419 3.8 ±0.4 132 2.1 ±0.4 195 6.5 ±0.9 92 13.9 ±2.8
Melanoma of Skin 2,334 20.3 ±0.8 497 8.0 ±0.7 1,264 42.0 ±2.3 573 86.4 ±7.0
Breast 7,637 63.9 ±1.4 1,227 19.6 ±1.1 4,840 160.8 ±4.4 1,570 236.8 ±11.4
Genitourinary Organs 14,494 115.2 ±1.9 1,208 19.3 ±1.1 9,976 331.5 ±6.2 3,310 499.3 ±16.0
Cervix Uteri 382 3.7 ±0.4 177 2.8 ±0.4 179 5.9 ±0.9 26 3.9 ±1.5
Corpus Uteri 1,846 14.4 ±0.7 178 2.9 ±0.4 1,382 45.9 ±2.4 286 43.1 ±5.0
Ovary 664 5.5 ±0.4 96 1.5 ±0.3 411 13.7 ±1.3 157 23.7 ±3.7
Prostate Gland 6,356 48.1 ±1.2 147 2.4 ±0.4 5,047 167.7 ±4.5 1,162 175.3 ±9.9
Other Genital 703 6.5 ±0.5 266 4.3 ±0.5 283 9.4 ±1.1 154 23.2 ±3.7
Urinary Bladder 2,589 20.9 ±0.8 84 1.3 ±0.3 1,420 47.2 ±2.4 1,085 163.7 ±9.5
Kidney and Renal Pelvis 1,821 15.1 ±0.7 256 4.1 ±0.5 1,192 39.6 ±2.2 373 56.3 ±5.7
Other Urinary 133 1.1 ±0.2 4 *   62 2.1 ±0.5 67 10.1 ±2.4
Brain & Other Central
Nervous System
706 6.2 ±0.5 199 3.2 ±0.4 374 12.4 ±1.3 133 20.1 ±3.4
Lymphomas 2,620 22.2 ±0.8 432 6.9 ±0.7 1,426 47.4 ±2.4 762 114.9 ±8.0
Hodgkin Lymphoma 240 2.3 ±0.3 139 2.2 ±0.4 79 2.6 ±0.6 22 3.3 ±1.4
Non-Hodgkin Lymphoma 2,380 19.9 ±0.8 293 4.7 ±0.5 1,347 44.8 ±2.4 740 111.6 ±7.9
Multiple Myeloma 884 7.2 ±0.5 54 0.9 ±0.2 534 17.7 ±1.5 296 44.6 ±5.1
Leukemias 1,620 13.6 ±0.7 238 3.8 ±0.5 870 28.9 ±1.9 512 77.2 ±6.6
All Other 3,749 32.9 ±1.0 810 13.0 ±0.9 1,786 59.3 ±2.7 1,153 173.9 ±9.8
Total 53,541 438.6 ±3.6 5,988 95.9 ±2.4 33,268 1105.4 ±10.3 14,285 2154.7 ±26.8
               

Notes: Age-Specific Rates are per 100,000 population in a specific age group. Age-Adjusted Rates are per 100,000 population. Age-adjusted rates are computed by the direct method, using as the standard population the age distribution of the total population of the United States for the year 2000. Adding and subtracting the number shown after the ± symbol from the rate creates a confidence interval indicating that the true rate lies between the lower and upper bounds of this interval with 95 % statistical confidence.
Case : A case is defined as a person with any newly diagnosed cancer with a behavior code of 3 (malignant primary site). Both in-situ and invasive urinary bladder cancer cases are included, in order to be consistent with SEER tabulations from the National Cancer Institute.
* : A rate is not calculated when there are fewer than 20 total events, or fewer than 6 events in an age category, because the width of the confidence interval would negate any usefulness for comparative purposes.
Source: Michigan Resident Cancer Incidence File. Updated with cases processed through November 30, 2017. Division for Vital Records & Health Statistics, Michigan Department of Health & Human Services.
Last Updated: October 31, 2018